Researchers Working on Conditional RNAi Gene Silencing in Transgenic Mice | GenomeWeb

With the benefits of using RNA interference to knock down gene expression in vivo well established, researchers are looking to take the technology one step further by developing transgenic mice in which the RNAi effect can be controlled.

At Baylor College of Medicine, Olga Cabello and colleagues are using a three-year grant from the National Eye Institute to test whether RNAi can be used to conditionally silence genes in transgenic mice while avoiding the stimulation of an interferon response.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.